PetIQ Inc
NASDAQ:PETQ
PetIQ Inc
NASDAQ:PETQ
Price:
30.98
USD
-0.03%
Market Closed
Market Cap:
$926.3m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
PetIQ Inc
NASDAQ:PETQ
|
US |
|
S
|
Syensqo SA
XBRU:SYENS
|
BE |
|
Strategic Education Inc
NASDAQ:STRA
|
US |
|
Catering International & Services SA
PAR:ALCIS
|
FR |
|
D
|
Douglas AG
XETRA:DOU
|
DE |
|
S
|
Scilex Holding Co
NASDAQ:SCLX
|
US |
|
Shenwan Hongyuan Group Co Ltd
SZSE:000166
|
CN |
|
TechPrecision Corp
NASDAQ:TPCS
|
US |
|
Eastroc Beverage Group Co Ltd
SSE:605499
|
CN |
|
Nice Ltd
NASDAQ:NICE
|
IL |
|
Creo Medical Group PLC
LSE:CREO
|
UK |
|
Akeso Inc
HKEX:9926
|
CN |
|
V
|
Vincenzo Zucchi SpA
MIL:ZUC
|
IT |
|
Shinnihon Corp
TSE:1879
|
JP |
|
Pierce Group AB (publ)
STO:PIERCE
|
SE |
|
P
|
Protean eGov Technologies Ltd
BSE:544021
|
IN |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PETQ.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PETQ
Multiples-Based Value
Base Case
Not Available
Multiples Across Competitors
PETQ Competitors Multiples
PetIQ Inc Competitors
PetIQ Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
PetIQ Inc
NASDAQ:PETQ
|
925m USD | 0.8 | 69.9 | 11.4 | 17.8 | |
| US |
|
Mckesson Corp
NYSE:MCK
|
107.2B USD | 0.3 | 24.7 | 17.4 | 19.5 | |
| US |
|
Cencora Inc
NYSE:COR
|
63.2B USD | 0.2 | 38.9 | 13.8 | 17.4 | |
| US |
A
|
Amerisourcebergen Corp
LSE:0HF3
|
62.3B USD | 0.2 | 38.3 | 13.6 | 17.1 | |
| US |
|
Cardinal Health Inc
NYSE:CAH
|
50.8B USD | 0.2 | 30.5 | 14.7 | 19.2 | |
| AU |
|
Sigma Healthcare Ltd
ASX:SIG
|
30.7B AUD | 2.7 | 34.1 | 25.4 | 25.4 | |
| CN |
|
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
|
64.1B CNY | 0.2 | 11.2 | 8.7 | 8.7 | |
| CN |
|
Huadong Medicine Co Ltd
SZSE:000963
|
63B CNY | 1.5 | 17 | 13.2 | 13.2 | |
| US |
|
Henry Schein Inc
NASDAQ:HSIC
|
8.7B USD | 0.7 | 22 | 10.8 | 15.3 | |
| CN |
|
Sinopharm Group Co Ltd
HKEX:1099
|
65.3B HKD | 0.1 | 8.2 | 0.7 | 0.9 | |
| KR |
|
Celltrion Healthcare Co Ltd
KOSDAQ:091990
|
12.2T KRW | 5.9 | 89.6 | 59.9 | 61.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
